|
RIPK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.32810000014794E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.94849999971092E-08 |
| Normal-vs-Stage2 |
9.356100E-02 |
| Normal-vs-Stage3 |
8.636100E-04 |
| Normal-vs-Stage4 |
6.815800E-02 |
| Stage1-vs-Stage2 |
1.088560E-01 |
| Stage1-vs-Stage3 |
9.094200E-02 |
| Stage1-vs-Stage4 |
1.680440E-02 |
| Stage2-vs-Stage3 |
6.638400E-01 |
| Stage2-vs-Stage4 |
7.483000E-01 |
| Stage3-vs-Stage4 |
3.061800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14890000002532E-06 |
| Normal-vs-AfricanAmerican |
3.069600E-02 |
| Normal-vs-Asian |
1.582540E-03 |
| Caucasian-vs-AfricanAmerican |
8.245400E-01 |
| Caucasian-vs-Asian |
3.424400E-01 |
| AfricanAmerican-vs-Asian |
4.024600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.823500E-04 |
| Normal-vs-Female |
1.26710000269981E-08 |
| Male-vs-Female |
2.043400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.495400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.20339999998276E-06 |
| Normal-vs-Age(61-80Yrs) |
2.42779999999332E-05 |
| Normal-vs-Age(81-100Yrs) |
1.599220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.098440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.939010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.070800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.041600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.285200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.468000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.378500E-03 |
| Normal-vs-Grade 2 |
5.76159997489611E-09 |
| Normal-vs-Grade 3 |
3.618700E-04 |
| Normal-vs-Grade 4 |
5.461000E-01 |
| Grade 1-vs-Grade 2 |
8.382000E-02 |
| Grade 1-vs-Grade 3 |
9.481600E-03 |
| Grade 1-vs-Grade 4 |
5.228500E-04 |
| Grade 2-vs-Grade 3 |
1.821530E-02 |
| Grade 2-vs-Grade 4 |
1.183090E-04 |
| Grade 3-vs-Grade 4 |
2.791600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68964842117703E-12 |
| Normal-vs-ccB subtype |
2.806800E-01 |
| ccA subtype-vs-ccB subtype |
2.90280022241518E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18089999999282E-05 |
| Normal-vs-N1 |
6.702000E-01 |
| N0-vs-N1 |
2.783800E-01 |
|
|
